Over the past 15 years, public health authorities have downgraded recommendations for the prostate-specific antigen (PSA) test as a screening tool to reduce the overdiagnosis and overtreatment of men ...

Nearly 67% of men with MRI-detected lesions and more than half of those with clinically significant prostate cancer had a PSA level less than 3 ng/mL, investigators reported. Using magnetic resonance ...

SAN FRANCISCO -- For patients with recurrent prostate cancer, those with a certain subtype had clinically meaningful benefits ...

The risk difference for the group randomized to the screening invitation compared with the control group who were not invited to undergo screening was 0.11% (95% CI 0.03-0.20) for low-grade cancer and ...

PSA testing rates increased after the U.S. Preventive Services Task Force revised its guidance on prostate cancer screening in 2017, according to results of a large national cohort study in JAMA ...

Enrollment was between October 2019 and December 2023, during which time 41 patients were assessed for eligibility and 32 patients were enrolled. The median age was 74.0 years (range: 61.0-82.0), the ...

LITTLE ROCK, Ark. — September is National Prostate Cancer Awareness Month, and we've been covering stories about conquering cancer— including a local pilot who felt he could have easily become a ...